BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/6/2026 7:34:30 AM | Browse: 72 | Download: 349
Publication Name Artificial Intelligence in Gastroenterology
Manuscript ID 118230
Country Argentina
ISSN 2644-3236 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright ©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Pathology
Manuscript Type Minireviews
Article Title Artificial intelligence in histopathology of inflammatory bowel disease: Toward objective and reproducible assessment of disease activity
Manuscript Source Invited Manuscript
All Author List Marcelo Fabián Amante
ORCID
Author(s) ORCID Number
Marcelo Fabián Amante http://orcid.org/0000-0002-0237-0713
Funding Agency and Grant Number
Corresponding Author Marcelo Fabián Amante, Chief, División Patología, Hospital General de Agudos Cosme Argerich, Pi y Margall 480, Buenos Aires C1155AHA, Buenos Aires, Ciudad Autónoma de, Argentina. marcelofabianamante@gmail.com
Key Words Artificial intelligence; Deep learning; Inflammatory bowel disease; Digital pathology; Histological remission; Precision medicine
Core Tip Artificial intelligence is revolutionizing inflammatory bowel disease histopathology by using deep learning on whole-slide images to automate analysis. This addresses the subjectivity of current scoring systems, offering objective, quantitative data for diagnosis, monitoring, and defining histological remission. While promising for clinical trials and precision medicine, challenges like algorithmic bias and integration into pathology workflows must be overcome through validation, regulation, and interdisciplinary collaboration.
Publish Date 2026-08-06 07:34
Citation

Amante MF. Artificial intelligence in histopathology of inflammatory bowel disease: Toward objective and reproducible assessment of disease activity. Artif Intell Gastroenterol 2026; 7(2): 118230

URL https://www.wjgnet.com/2644-3236/full/v7/i2/118230.htm
DOI https://doi.org/10.35712/aig.v7.i2.118230
Full Article (PDF) AIG-7-118230-with-cover.pdf